CN111818927A - 用于治疗炎性皮肤疾病的米诺环素 - Google Patents

用于治疗炎性皮肤疾病的米诺环素 Download PDF

Info

Publication number
CN111818927A
CN111818927A CN201980017148.7A CN201980017148A CN111818927A CN 111818927 A CN111818927 A CN 111818927A CN 201980017148 A CN201980017148 A CN 201980017148A CN 111818927 A CN111818927 A CN 111818927A
Authority
CN
China
Prior art keywords
doxycycline
composition
minocycline
rosacea
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980017148.7A
Other languages
English (en)
Chinese (zh)
Inventor
S·库尔卡尼
B·K·帕德西
S·阿里昆朱
R·S·拉古万施
S·R·斯基迪
A·高塔姆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65269058&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN111818927(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of CN111818927A publication Critical patent/CN111818927A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201980017148.7A 2018-01-07 2019-01-07 用于治疗炎性皮肤疾病的米诺环素 Pending CN111818927A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Publications (1)

Publication Number Publication Date
CN111818927A true CN111818927A (zh) 2020-10-23

Family

ID=65269058

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980017148.7A Pending CN111818927A (zh) 2018-01-07 2019-01-07 用于治疗炎性皮肤疾病的米诺环素

Country Status (11)

Country Link
US (4) US11191740B2 (https=)
EP (1) EP3735249A1 (https=)
JP (3) JP7561029B2 (https=)
KR (1) KR102705507B1 (https=)
CN (1) CN111818927A (https=)
AU (2) AU2019205134B9 (https=)
BR (1) BR112020013789A2 (https=)
CA (1) CA3087838A1 (https=)
EA (1) EA202091653A1 (https=)
MX (1) MX2020007222A (https=)
WO (1) WO2019135166A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119732960A (zh) * 2025-03-05 2025-04-01 福安药业集团宁波天衡制药有限公司 一种盐酸米诺环素胶囊及其制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン
CA3106884C (en) * 2018-07-19 2025-04-01 Doosan Bobcat North America, Inc. DISPLAY POSITION FOR CABIN WITH TILTING DOOR

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221056A1 (en) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyclines for the treatment of acne
US20120093892A1 (en) * 2005-06-24 2012-04-19 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
JP7561029B2 (ja) 2018-01-07 2024-10-03 ドクター レディズ ラボラトリーズ リミテッド 炎症性皮膚状態を処置するためのミノサイクリン

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2221056A1 (en) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyclines for the treatment of acne
US20120093892A1 (en) * 2005-06-24 2012-04-19 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BIKOWSKI J. B.: ""SUBANTIMICROBIAL DOSE DOXYCYCLINE FOR ACNE AND ROSACEA"", 《SKINMED：DERMATOLOGY FOR THE CLINICIAN》 *
LEYDEN JAMES J. 等: ""Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorder: a status report"", 《DERMATOLOGIC CLINICS》 *
ZOUBOULIS C. C.等: ""UPDATE AND FUTURE OF SYSTEMIC ACNE TREATMENT"", 《DERMATOLOGY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119732960A (zh) * 2025-03-05 2025-04-01 福安药业集团宁波天衡制药有限公司 一种盐酸米诺环素胶囊及其制备方法

Also Published As

Publication number Publication date
EA202091653A1 (ru) 2020-12-23
CA3087838A1 (en) 2019-07-11
KR102705507B1 (ko) 2024-09-10
WO2019135166A9 (en) 2020-07-16
AU2019205134A1 (en) 2020-08-20
US10905664B2 (en) 2021-02-02
AU2019205134B2 (en) 2024-11-07
RU2020125984A3 (https=) 2022-02-07
US12594252B2 (en) 2026-04-07
KR20200108018A (ko) 2020-09-16
BR112020013789A2 (pt) 2021-02-17
JP2026031656A (ja) 2026-02-24
JP2021509409A (ja) 2021-03-25
US20200222345A1 (en) 2020-07-16
RU2020125984A (ru) 2022-02-07
AU2019205134A2 (en) 2020-08-20
EP3735249A1 (en) 2020-11-11
US11191740B2 (en) 2021-12-07
AU2019205134B9 (en) 2025-02-20
JP7561029B2 (ja) 2024-10-03
JP2024098011A (ja) 2024-07-19
US20190209500A1 (en) 2019-07-11
WO2019135166A1 (en) 2019-07-11
US20210121420A1 (en) 2021-04-29
MX2020007222A (es) 2020-12-10
US11364212B2 (en) 2022-06-21
AU2025200826A1 (en) 2025-02-27
US20230131030A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
TWI473610B (zh) 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
JP6888226B2 (ja) オラパリブの経口徐放性医薬組成物及びその使用
WO2009034541A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
US12594252B2 (en) Methods for treating inflammatory skin conditions
CN102348455A (zh) 药物剂型的活性包衣
WO2018108157A1 (zh) 一种瑞卡帕布口服缓控释药物组合物及其用途
JP2013504615A (ja) 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
EP2701689B1 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
RU2787528C2 (ru) Миноциклин для лечения воспалительных заболеваний кожи
HK40039196A (en) Minocycline for treating inflammatory skin conditions
EP3275434B1 (en) An extended release oral dosage form
EA045615B1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
JP6259043B2 (ja) 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
TWI743059B (zh) 二氟甲基鳥氨酸及舒林酸（ｓｕｌｉｎｄａｃ），固定劑量組合調配物
JP6078514B2 (ja) 溶出率向上と副作用発現が最小化されたシルロスタゾール徐放錠
KR20130094117A (ko) 록소프로펜 방출제어형 제제 및 이의 제조방법

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40039196

Country of ref document: HK